Condition
Protein Intolerance
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04771377Not ApplicableCompleted
Effect of Protein Supplementation and a Structured Exercise Program on Muscle in Women After Bariatric Surgery.
NCT04615858Not ApplicableUnknown
Genepro Generation 3 Protein Bioavailability Compared to Whey Protein
NCT03698058Not ApplicableCompletedPrimary
A2 GUM Post-Market Effectiveness Study
NCT03884309Not ApplicableCompletedPrimary
Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula
Showing all 4 trials